This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2f3k
From Proteopedia
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
| - | In our previous crystallographic studies of human immunodeficiency virus | + | In our previous crystallographic studies of human immunodeficiency virus type 1 (HIV-1) protease-substrate complexes, we described a conserved "envelope" that appears to be important for substrate recognition and the selection of drug-resistant mutations. In this study, the complex of HIV-1 protease with the inhibitor RO1 was determined and comparison with the substrate envelope provides a rationale for mutational patterns. |
==About this Structure== | ==About this Structure== | ||
| Line 16: | Line 16: | ||
[[Category: Cammack, N.]] | [[Category: Cammack, N.]] | ||
[[Category: Heilek-Snyder, G.]] | [[Category: Heilek-Snyder, G.]] | ||
| - | [[Category: King, N | + | [[Category: King, N M.]] |
| - | [[Category: Nalivaika, E | + | [[Category: Nalivaika, E A.]] |
[[Category: Prabu-Jeyabalan, M.]] | [[Category: Prabu-Jeyabalan, M.]] | ||
| - | [[Category: Schiffer, C | + | [[Category: Schiffer, C A.]] |
[[Category: PO4]] | [[Category: PO4]] | ||
[[Category: RO1]] | [[Category: RO1]] | ||
| Line 27: | Line 27: | ||
[[Category: substrate envelope]] | [[Category: substrate envelope]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:17:23 2008'' |
Revision as of 15:17, 21 February 2008
|
Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease
Overview
In our previous crystallographic studies of human immunodeficiency virus type 1 (HIV-1) protease-substrate complexes, we described a conserved "envelope" that appears to be important for substrate recognition and the selection of drug-resistant mutations. In this study, the complex of HIV-1 protease with the inhibitor RO1 was determined and comparison with the substrate envelope provides a rationale for mutational patterns.
About this Structure
2F3K is a Single protein structure of sequence from Human immunodeficiency virus 1 with and as ligands. Active as HIV-1 retropepsin, with EC number 3.4.23.16 Full crystallographic information is available from OCA.
Reference
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease., Prabu-Jeyabalan M, King NM, Nalivaika EA, Heilek-Snyder G, Cammack N, Schiffer CA, Antimicrob Agents Chemother. 2006 Apr;50(4):1518-21. PMID:16569872
Page seeded by OCA on Thu Feb 21 17:17:23 2008
